Gnubiotics and Penn Explore CAR-T Therapy
This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.
Five Years of Data Show Long-term Promise for Penn and Novartis’ Car-T Pioneer Kymriah
Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates.
Penn Partners with PaxeraHealth to Build AI Algorithms for Ultrasound Research
The collaboration between Penn and PaxeraHealth will concentrate on developing imaging algorithms to detect liver cancer in addition to covid detection via lung ultrasounds.
Tribeca Film Festival Documentary Features CAR-T Journey
Penn Medicine and Children’s Hospital of Philadelphia were in the spotlight at the Tribeca Film Festival in New York City, where the documentary “Of Medicine and Miracles" premiered.
Penn Engineering Graduates Develop a Device to Reduce Ocean Microplastic Pollution
Read about how May graduates won the 2022 President's Sustainability Prize for their device that reduces microplastic pollution.
New ASSET Center
Penn Engineering’s newly formed ASSET (AI-enabled Systems: Safety, Explainablity and Trustworthiness) Center is part of Penn Engineering’s Innovation in Data Engineering & Science (IDEAS) Initiative.
COVID Vaccines and Boosters Provoke Robust Immune Response
Several new research studies reported in the New York Times have demonstrated that multiple doses of a COVID vaccine elicit a durable response in most people that protects them from serious illness
Newly discovered ‘encrypted peptides’ with antibiotic properties
A new study reports three distinct proteins in human plasma that have naturally occurring antibiotic properties. Global public health officials are concerned about the r
Decade-long remission after CAR T cell therapy
Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.
ExynAI has been shortlisted as a finalist for a SXSW Innovation Award
For the 2022 category of Robotics and Hardware. The Exyn team will be going to Austin for the awards.